← Leaderboards
John Dubach
Massachusetts General Hospital
$3,250,379
Attributed
$3,497,071
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $633.3K · FY2015–25$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,497,071 · 4
By mechanism
R01$1,907,149 · 1
R00$738,422 · 1
R42$493,384 · 1
K99$358,116 · 1
Top collaborators
- Rachel Elise Bennett1 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Jing Zhou$20,912,829
- Sekar Kathiresan$50,580,753
- Kamila Naxerova$7,833,583
- Catherine J Chu$5,818,688
- Robert L Martuza$21,256,149
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsInsightPoly(Adp-Ribose) PolymerasesHeterogeneityCancer TherapyTumorBiologyMalignant NeoplasmsPathway InteractionsPharmaceutical PreparationsProteinsResponseCellsDrug DistributionAlzheimer&AposBindingInhibitor/AntagonistDoseToxic EffectMutationComplexBiological MarkersChromatinClinical Application
Grant awards (11)
An Eyedrop Diagnostic Test for Alzheimer's Disease$493,384
R42 · FY2025 · AG · contact PI
Optimizing PARP inhibitor therapy through novel approaches to resolve the molecular mechanisms of response$374,937
R01 · FY2023 · CA · contact PI
Optimizing PARP inhibitor therapy through novel approaches to resolve the molecular mechanisms of response$382,589
R01 · FY2022 · CA · contact PI
Optimizing PARP inhibitor therapy through novel approaches to resolve the molecular mechanisms of response$382,637
R01 · FY2021 · CA · contact PI
Optimizing PARP inhibitor therapy through novel approaches to resolve the molecular mechanisms of response$382,686
R01 · FY2020 · CA · contact PI
Optimizing PARP inhibitor therapy through novel approaches to resolve the molecular mechanisms of response$384,300
R01 · FY2019 · CA · contact PI
The role of PARP inhibitor target engagement in breast cancer$249,000
R00 · FY2019 · CA · contact PI
The role of PARP inhibitor target engagement in breast cancer$240,422
R00 · FY2018 · CA · contact PI
The role of PARP inhibitor target engagement in breast cancer$249,000
R00 · FY2017 · CA · contact PI
The role of PARP inhibitor target engagement in breast cancer$179,058
K99 · FY2016 · CA · contact PI
The role of PARP inhibitor target engagement in breast cancer$179,058
K99 · FY2015 · CA · contact PI